26th February 2024
11 AM to 12 PM
Time Zone: UAE
Location: The Council's Auditorium - Ground Floor
Rod’s passion for innovative science and its power to impact people’s lives led him to launch RTW in 2009. His rigorous approach to analyzing the latest science and narrowing in on the ideas with the best potential formed the foundation of what the firm is today. Over the last 13 years, Rod has built a diverse team of scientists, entrepreneurs, dealmakers, and operators with the capabilities to find those promising scientific innovations and power their development into life-changing medicine. In addition to his leadership of the firm, Rod manages the firm’s investments focused on innovative drug development. Prior to forming RTW, he was a Managing Director and sole Portfolio Manager for the Davidson Kempner Healthcare Funds. Before joining Davidson Kempner, Rod held various healthcare investment and research roles at Sigma Capital Partners and Cowen & Company. Rod graduated Phi Beta Kappa from Duke University, received a Medical Degree from the University of Pennsylvania School of Medicine, and an MBA from Harvard Business School.
Stephanie leads a team at RTW overseeing business development, strategic partnerships, communications, and investor relations. Her background in investment banking and expertise in financial markets has helped position the firm as both a partner to life sciences companies and a steward of investors’ capital. Stephanie also manages RTW’s relationships with key partners including banks, academic institutions, corporations, investors, and NGOs. She has led the firm’s entry into the UK and European markets and serves as a director of the RTW Biotech Opportunities Ltd, a publicly traded investment fund listed on the London Stock Exchange. Stephanie received a BA from Columbia University and a Master’s of Science from the Columbia Graduate School of Journalism.
Woody is a member of the Strategic Partnerships team and is responsible for helping to build and engage with strategic and institutional partners internationally. Woody’s primary responsibility includes capital raising across the firm’s various institutional products. He also serves as Head of Office in the UK. Prior to joining RTW, Woody was Head of Investor Relations and Business Development at Tower House Partners. Before that, he was responsible for International and Institutional Investor Relations and Business Development at Odey Asset Management. He began his career in Equity Capital Markets at Dresdner Kleinwort before moving onto the buyside at Waverton Investment Management (formerly JO Hambro) where he ultimately managed their Asian equity portfolios. Woody graduated with a First Class MA Hons in Psychology from the University of Edinburgh.